| Jihad Samir Isteitiya, MD | |
|
8300 Floyd Curl Dr Fl 6, San Antonio, TX 78229 | |
| (210) 450-9400 | |
| (210) 450-6024 |
| Full Name | Jihad Samir Isteitiya |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 19 Years |
| Location | 8300 Floyd Curl Dr Fl 6, San Antonio, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104203074 | NPI | - | NPPES |
| 382194402 | Other | TX | CSHCN |
| 382194401 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | P01935 (New York) | Secondary |
| 207W00000X | Ophthalmology | FT548 (Kentucky) | Secondary |
| 207W00000X | Ophthalmology | 46268 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shah Eye Center Pa | 7214935543 | 7 |
News Archive
New research from the Johns Hopkins Bloomberg School of Public Health suggests that the protein keratin 17 - the presence of which is used in the lab to detect and stage various types of cancers - is not just a biomarker for the disease, but may play a critical role in tumor growth.
SDI and Cegedim Strategic Data (CSD) announced today that they will jointly launch a new market research service that tracks selling activities in the oncology therapeutic market. The Oncology Selling Audit will be released in January 2011; 2 years of history will be available for reporting and analysis.
As the Zika virus continues to spread rapidly across the globe, it might pose a particular risk to people previously infected with two related viruses, dengue and West Nile, researchers at the Icahn School of Medicine at Mount Sinai have found.
People who receive opioids for the first time while hospitalized have double the risk of continuing to receive opioids for months after discharge compared with their hospitalized peers who are not given opioids, according to research led by scientists at the University of Pittsburgh Graduate School of Public Health.
› Verified 2 days ago
| Entity Name | University Of Texas Health Science Center At San Antonio |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720051717 PECOS PAC ID: 0042128548 Enrollment ID: O20040607000664 |
News Archive
New research from the Johns Hopkins Bloomberg School of Public Health suggests that the protein keratin 17 - the presence of which is used in the lab to detect and stage various types of cancers - is not just a biomarker for the disease, but may play a critical role in tumor growth.
SDI and Cegedim Strategic Data (CSD) announced today that they will jointly launch a new market research service that tracks selling activities in the oncology therapeutic market. The Oncology Selling Audit will be released in January 2011; 2 years of history will be available for reporting and analysis.
As the Zika virus continues to spread rapidly across the globe, it might pose a particular risk to people previously infected with two related viruses, dengue and West Nile, researchers at the Icahn School of Medicine at Mount Sinai have found.
People who receive opioids for the first time while hospitalized have double the risk of continuing to receive opioids for months after discharge compared with their hospitalized peers who are not given opioids, according to research led by scientists at the University of Pittsburgh Graduate School of Public Health.
› Verified 2 days ago
| Entity Name | Shah Eye Center Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639114291 PECOS PAC ID: 7214935543 Enrollment ID: O20061121000595 |
News Archive
New research from the Johns Hopkins Bloomberg School of Public Health suggests that the protein keratin 17 - the presence of which is used in the lab to detect and stage various types of cancers - is not just a biomarker for the disease, but may play a critical role in tumor growth.
SDI and Cegedim Strategic Data (CSD) announced today that they will jointly launch a new market research service that tracks selling activities in the oncology therapeutic market. The Oncology Selling Audit will be released in January 2011; 2 years of history will be available for reporting and analysis.
As the Zika virus continues to spread rapidly across the globe, it might pose a particular risk to people previously infected with two related viruses, dengue and West Nile, researchers at the Icahn School of Medicine at Mount Sinai have found.
People who receive opioids for the first time while hospitalized have double the risk of continuing to receive opioids for months after discharge compared with their hospitalized peers who are not given opioids, according to research led by scientists at the University of Pittsburgh Graduate School of Public Health.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jihad Samir Isteitiya, MD 8300 Floyd Curl Dr, San Antonio, TX 78229-3931 Ph: (210) 450-9000 | Jihad Samir Isteitiya, MD 8300 Floyd Curl Dr Fl 6, San Antonio, TX 78229 Ph: (210) 450-9400 |
News Archive
New research from the Johns Hopkins Bloomberg School of Public Health suggests that the protein keratin 17 - the presence of which is used in the lab to detect and stage various types of cancers - is not just a biomarker for the disease, but may play a critical role in tumor growth.
SDI and Cegedim Strategic Data (CSD) announced today that they will jointly launch a new market research service that tracks selling activities in the oncology therapeutic market. The Oncology Selling Audit will be released in January 2011; 2 years of history will be available for reporting and analysis.
As the Zika virus continues to spread rapidly across the globe, it might pose a particular risk to people previously infected with two related viruses, dengue and West Nile, researchers at the Icahn School of Medicine at Mount Sinai have found.
People who receive opioids for the first time while hospitalized have double the risk of continuing to receive opioids for months after discharge compared with their hospitalized peers who are not given opioids, according to research led by scientists at the University of Pittsburgh Graduate School of Public Health.
› Verified 2 days ago
Dr. Robert Alan Rice, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1 Haven For Hope Way, San Antonio, TX 78207 Phone: 102-220-2368 Fax: 210-220-2499 | |
Dr. Ricardo Nathaniel Sepulveda, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8002 West Ave, San Antonio, TX 78213 Phone: 210-348-8788 Fax: 210-348-8768 | |
Aaron Pittard, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 11601 Toepperwein Rd, San Antonio, TX 78233 Phone: 210-946-2020 | |
Dr. Wendy Baca, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10935 Wurzbach, #202, San Antonio, TX 78230 Phone: 210-377-3937 Fax: 210-342-2375 | |
Fernando Trujillo, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 999 E Basse Rd, Ste 103, San Antonio, TX 78209 Phone: 210-538-2020 Fax: 210-599-6622 | |
Dr. Barbara L. Ku, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1100 N Main Ave, San Antonio, TX 78212 Phone: 210-222-2154 Fax: 210-227-6056 | |
Dr. Gregory Brunin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5430 Fredericksburg Rd Ste 100, San Antonio, TX 78229 Phone: 210-340-1212 |